A 'pain-free' death

British Medical Bulletin

Volumn 88, Issue 1, 2008, Pages 23-41

  Hicks, Fiona ^a,b   Rees, Elizabeth ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

End of life care; Pain; Review; Terminal care

Indexed keywords

ALFENTANIL; AMITRIPTYLINE; ANALGESIC AGENT; ANTIEMETIC AGENT; BUPRENORPHINE; CARBAMAZEPINE; CLONAZEPAM; CODEINE; DEXAMETHASONE; DIAMORPHINE; DICLOFENAC; FENTANYL; GABAPENTIN; HALOPERIDOL; KETAMINE; KETOROLAC; LEVOMEPROMAZINE; METHADONE; MIDAZOLAM; MORPHINE; MORPHINE SULFATE; NALOXONE; OPIATE; OXYCODONE; PARACETAMOL; PIROXICAM; SEDATIVE AGENT;

ADD ON THERAPY; AGITATION; ANALGESIA; ANAMNESIS; BEHAVIOR CHANGE; BONE PAIN; CAREGIVER; CLINICAL PATHWAY; CONSTIPATION; CONTINUOUS INFUSION; DEATH; DELIRIUM; DISEASE CLASSIFICATION; DISTRESS SYNDROME; DOSE CALCULATION; DROWSINESS; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG SUBSTITUTION; DYING; EXPERIMENTAL THERAPY; HEALTH CARE DELIVERY; HOME CARE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; LIFE EVENT; LOW DRUG DOSE; MEDICAL STAFF; MEDICOLEGAL ASPECT; MYALGIA; MYOCLONUS; NAUSEA AND VOMITING; NEUROPATHIC PAIN; NURSING HOME; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PALLIATIVE THERAPY; PATIENT ASSESSMENT; PATIENT CARE; PATIENT POSITIONING; PEPTIC ULCER; PHARMACEUTICAL CARE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STAFF TRAINING; TERMINAL CARE; TERMINAL DISEASE; UNITED KINGDOM; VISCERAL PAIN;

ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO DEATH; CRITICAL PATHWAYS; HUMANS; PAIN; PALLIATIVE CARE; TERMINAL CARE;

EID: 57749169239     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldn043     Document Type: Review

References (55)

1. Department of Health (2003) End of Life Care Programme, available at: www.endoflifecare.nhs.uk/eolc
2. Department of Health (2000) The NHS Cancer Plan: A Plan for Investment, A Plan for Reform, available at: www.dh.gov.uk
3. Department of Health (2008) End of life care strategy. Promoting High Quality Care For All Adults At The End of Life. London, available at: www.dh.gov.uk
4. Stone P, Rees E, Hardy JR (2001) End of life care in patients with malignant disease. Eur J Cancer, 37, 1070-1075.
5. Weiss SC, Emanuel LL, Fairclough DL, Emanuel EJ (2001) Understanding the experience of pain in terminally ill patients. Lancet, 357, 1311-1314.
6. Office for National Statistics (2006), available at: www.statistics.org. uk
7. Solano JP, Gomes B, Higginson IJ (2006) A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage, 31, 58-68.
8. Addington-Hall, available at: www.wun.ac.uk/wunnursing/seminars/2006
9. Payne SA, Langley-Evans A, Hillier R (1996) Perceptions of a "good death": a comparative study of the views of hospice staff and patients. Palliat Med 10, 307-312.
10. National Council for Palliative Care (2006) Changing Gear - Guidelines for Managing the Last Days of Life in Adults, available at: www.ncpc.org.uk
11. Steinhauser KE, Christakis NA, Clipp EC et al. (2000) Factors considered important at the end of life by patients, family, physicians and other care providers. JAMA, 284, 2476-2482.
12. Firth S (2001) Wider Horizons. Care of the dying in a multicultural society. National Council for Hospice and Specialist Palliative Care Services.
13. Gatrad AR, Brown E, Notta H, Sheikh A (2003) Palliative care needs of minorities. Br Med J, 327, 176-177.
14. Welsh J, Fallon M, Urie J (1997) Doctors', nurses' and pharmacists' beliefs about dependence on and tolerance to opioid analgesics in cancer patients. Proceedings of the Fifth Congress of the European Association of Palliative Care, London.
15. Portenoy RK, Sibirceva U, Smout R et al. (2006) Opioid use and survival at the end of life: a survey of a hospice population. J Pain Symptom Manage, 32, 532-540.
16. Prescribing in palliative care (2008) British National Formulary for Children, available at: www.bnfc.org
17. Edmonds P, Karlson S, Khan S, Addington-Hall J (2001) A comparison of the palliative care needs of patients dying from chronic respiratory disease and lung cancer. Palliat Med, 15, 287-295.
18. Tuffrey-Wijne I, McEnhill L (2008) Communication difficulties and intellectual disability in end-of-life care. Int J Palliat Nurs, 14, 189-194.
19. The National Council for Palliative Care (2008) Creative Partnerships - Improving the Quality of Life at the End of Life for People with Dementia, available at: www.ncpc.org.uk
20. Royal College of Physicians, British Geriatric Society, British Pain Society (2007) The Assessment of Pain in Older Adults, available at: www.bgs.org
21. Mularski R, Curtis R, Osborne M et al. (2004) Agreement among family members in their assessment of the quality of dying and death. J Pain Symptom Manage, 28, 306-315.
22. Tang ST, McCorkle R (2002) Use of family proxies in quality of life research for cancer patients at the end of life: a literature review. Cancer Invest, 20, 1086-1104.
23. Higginson IJ, Priest P, McCarthy M (1994) Are bereaved family members a valid proxy for a patient's assessment of dying? Soc Sci Med, 38, 553-557.
24. Daut RL, Cleeland CS, Flanery RC (1983) Development of the Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain, 17, 197-210.
25. Regnard C, Reynolds J, Watson B et al. (2007) Understanding distress in people with severe communication difficulties: developing and assessing the Disability Distress Assessment Tool (DisDAT). J Intellect Disabil Res, 51, 277-292.
26. Herr K, Bjoro K, Decker S (2006) Tools for the assessment of pain in non-verbal older adults with dementia: a state-of-the-science review. J Pain Symptom Manage, 31, 170-192.
27. Saunders CM (1967) The Management of Terminal Illness. London: Hospital Medicine Publications.
28. Ashby M, Stoffell B (1991) Therapeutic ratio and defined phases: proposal of an ethical framework for palliative care. Br Med J, 302, 1322-1324.
29. The Association for Palliative Medicine for Great Britain and Ireland and the British Pain Society (2005) The Use Of Drugs Beyond Licence In Palliative Care And Pain Management, available at: www.britishpainsociety. org
30. Stevenson J, Abernethy AP, Miller C, Currow DC (2004) Managing co-morbidities in patients at the end of life. Br Med J, 329, 909-912.
31. Expert Working Group of the Research Network of the European Association for Palliative Care (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer, 84, 587-593.
32. British National Formulary 55. March 2008, available at: www.bnf.org
33. Twycross R, Wilcock A (2007) Analgesics. In Palliative Care Formulary, 3rd ed. Palliativedrugs.com Ltd, 209-322
34. Hugel H, Ellershaw J, Dickman A (2003) Clonazepam as an adjuvant analgesic in patients with cancer related neuropathic pain. J Pain Symptom Manage, 26, 1073-1074.
35. Mercadante S, Lodi F, Sapio M et al. (1999) Long term ketamine subcutaneous infusion in neuropathic cancer pain. J Pain Symptom Manage, 17, 296-230.
36. Gannon C (1997) The use of methadone in the care of the dying. Eur J Pall Care, 4, 152-158.
37. Dickman A, Schneider J, Varga J (2005) Ketorolac. In The Syringe Driver - Continuous Subcutaneous Infusions in Palliative Care, 2nd ed. Oxford: Oxford University Press, 60-61.
38. Zepepetella G, Ribeiro MD (2005 ) Morphine in intrasite gel applied topically to painful ulcers. J Pain Symptom Manage, 29, 118-119.
39. Kaiko RF, Benziger DP, Fitzmartin RD et al. (1996) Clinical pharmacokinetics of controlled release oxycodone in renal impairment. Clin Pharmacol Ther, 59, 52-61.
40. Urch CE, Carr S, Minton O (2004) A retrospective review of the use of alfentanil in a hospital palliative care setting. Palliat Med, 18, 516-519.
41. Scholz J, Steinfaith M, Schulz M (1996) Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update. Clin pharmacokinet, 4, 275-292.
42. Hand CW, Sear JW, Uppingham J et al. (1990) Buprenorphine disposition in patients with renal impairment: single and continuous dosing with special reference to metabolites. Br J Anaesth, 64, 276-282.
43. Lasseter KC, Venitz J, Eltahtawy A et al. (2001) Systematic pharmacokinetic study of buprenorphine in mild to moderate hepatic impairment. Clin Pharmacol Ther, 69, 2.
44. Twycross R, Wilcock A (2007) Analgesics. In Palliative Care Formulary, 3rd ed. Palliativedrugs.com Ltd, 284-287, 289-296, 297-306.
45. Hanks G, Cherny NI, Fallon M (2005) Opioid analgesic therapy. In Doyle D, Hanks G, Cherny NI, Calman K (eds) Oxford Textbook of Palliative Medicine, 3rd ed. Oxford: Oxford University Press, 334-335.
46. Department of Health (2000) National Service Framework (NSF) for Coronary Heart Disease. London: Department of Health, available at: www.dh.gov.uk
47. Department of Health (2005) National Service Framework (NSF) for Long Term Conditions. London: Department of Health, available at: www.dh.gov.uk
48. Department of Health (2005). National Service Framework (NSF) for Renal Disease. London: Department of Health, available at: www.dh.gov.uk
49. NICE: Improving Supportive and Palliative Care for Adults with Cancer (2001) Department of Health.
50. Ellershaw J, Wilkinson S (2003) Care of the Dying. A Pathway to Excellence. Oxford: Oxford University Press.
51. Ellershaw J, Ward C (2003) Care of the dying patient: the last hours or days of life. Br Med J, 326, 30-34.
52. Thomas K (2003) The Gold Standards Framework in community palliative care. Eur J Pall Care, 10, 113-115.
53. Pemberton C, Storey L, Howard A (2003) The preferred place of care document: an opportunity for communication. Int J Palliat Nurs, 9, 439-441.
54. The NHS Knowledge and Skills Framework (NHS KSF) and the Development Review Process (2004). London: Department of Health.
55. Royal College of Physicians Report of a Working Party (2007) Palliative Care Services, Meeting the Needs of Patients, 29-32.